| Rosuvastatin |
20040104 |
Crestor, Film coated tablet, 10, mg, Pack: 28 |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca UK Limited, Великобритания |
29.1 |
5.82 |
34.92 |
6% |
1.75 |
30.85 |
6.17 |
37.02 |
18% |
5.24 |
36.09 |
7.22 |
43.31 |
Отхвърлена жалба от Комисия по прозрачност с решение КП-102/06.04.2015; Промяна на обстоятелства НСР-14157/13.10.2017 |
НСР-4293/05.08.2014.; НСР-16138/13.07.2018 |
02.08.2018 |
02.08.2018 |
Заличен |
3795 |
| Rosuvastatin |
II-8675/ 08.03.2004 |
Crestor, Film coated tablet, 10, mg, Pack: 28 |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca GmbH, Germany |
29.1 |
5.82 |
34.92 |
6% |
1.75 |
30.85 |
6.17 |
37.02 |
18% |
5.24 |
36.09 |
7.22 |
43.31 |
Отхвърлена жалба от Комисия по прозрачност с решение КП-102/06.04.2015; Промяна на обстоятелства НСР-14157/13.10.2017 |
НСР-4293/05.08.2014. |
02.05.2015 |
02.11.2017 |
Неактивен |
3795 |
| Rosuvastatin |
II-8675/ 08.03.2004 |
Crestor, Film coated tablet, 10, mg, Pack: 28 |
AstraZeneca Pharmaceuticals AB, Швеция |
AstraZeneca GmbH, Germany |
29.1 |
5.82 |
34.92 |
6% |
1.75 |
30.85 |
6.17 |
37.02 |
18% |
5.24 |
36.09 |
7.22 |
43.31 |
Отхвърлена жалба от Комисия по прозрачност с решение КП-102/06.04.2015 |
НСР-4293/05.08.2014. |
02.05.2015 |
02.05.2015 |
Неактивен |
3795 |
| Rosuvastatin |
II-8675/ 08.03.2004 |
Crestor, Film coated tablet, 10, mg, Pack: 28 |
AstraZeneca Pharmaceuticals AB, Швеция |
AstraZeneca GmbH, Germany |
31.94 |
6.39 |
38.33 |
4% |
1.28 |
33.22 |
6.64 |
39.86 |
16% |
5.11 |
38.33 |
7.67 |
46 |
|
КЦРР-565/04.05.2012 |
22.05.2012 |
22.05.2012 |
Неактивен |
3795 |
| Rosuvastatin |
II-8675/ 08.03.2004 |
Crestor, Film coated tablet, 10, mg, Pack: 28 |
AstraZeneca Pharmaceuticals AB, Швеция |
AstraZeneca GmbH, Germany |
36.75 |
7.35 |
44.1 |
6% |
2.21 |
38.96 |
7.79 |
46.75 |
18% |
6.62 |
45.57 |
9.11 |
54.68 |
|
КЦ-389/07.01.2009 |
26.01.2009 |
26.01.2009 |
Неактивен |
3795 |
| Rosuvastatin |
20040105 |
CRESTOR, Film coated tablet, 20, mg, Pack: 28 |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca UK Limited, Великобритания |
44.89 |
8.98 |
53.87 |
4% |
1.8 |
46.69 |
9.34 |
56.03 |
16% |
7.18 |
53.87 |
10.77 |
64.64 |
Промяна на обстоятелства НСР-14157/13.10.2017 |
НСР-8435/07.03.2016; НСР-16137/13.07.2018 |
02.08.2018 |
02.08.2018 |
Заличен |
2405 |
| Rosuvastatin |
20040105 |
CRESTOR, Film coated tablet, 20, mg, Pack: 28 |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca GmbH, Germany |
44.89 |
8.98 |
53.87 |
4% |
1.8 |
46.69 |
9.34 |
56.03 |
16% |
7.18 |
53.87 |
10.77 |
64.64 |
Промяна на обстоятелства НСР-14157/13.10.2017 |
НСР-8435/07.03.2016 |
22.03.2016 |
02.11.2017 |
Неактивен |
2405 |
| Rosuvastatin |
20040105 |
CRESTOR, Film coated tablet, 20, mg, Pack: 28 |
AstraZeneca Pharmaceuticals AB, Швеция |
AstraZeneca GmbH, Germany |
44.89 |
8.98 |
53.87 |
4% |
1.8 |
46.69 |
9.34 |
56.03 |
16% |
7.18 |
53.87 |
10.77 |
64.64 |
|
НСР-8435/07.03.2016 |
22.03.2016 |
22.03.2016 |
Неактивен |
2405 |
| Rosuvastatin |
20040105 |
CRESTOR, Film coated tablet, 20, mg, Pack: 28 |
AstraZeneca Pharmaceuticals AB, Швеция |
AstraZeneca GmbH, Germany |
48.11 |
9.62 |
57.73 |
4% |
1.92 |
50.03 |
10.01 |
60.04 |
16% |
7.7 |
57.73 |
11.55 |
69.28 |
|
НСР-2187/20.12.2013 |
27.01.2014 |
27.01.2014 |
Неактивен |
2405 |
| Rosuvastatin |
20040105 |
CRESTOR, Film coated tablet, 20, mg, Pack: 28 |
AstraZeneca Pharmaceuticals AB, Швеция |
AstraZeneca GmbH, Germany |
48.49 |
9.7 |
58.19 |
4% |
1.94 |
50.43 |
10.09 |
60.52 |
16% |
7.76 |
58.19 |
11.64 |
69.83 |
|
КЦРР-2833/20.03.2013 |
24.04.2013 |
24.04.2013 |
Неактивен |
2405 |
| Rosuvastatin |
II-8676/ 08.03.2004 |
CRESTOR, Film coated tablet, 20, mg, Pack: 28 |
AstraZeneca Pharmaceuticals AB, Швеция |
AstraZeneca GmbH, Germany |
48.76 |
9.75 |
58.51 |
4% |
1.95 |
50.71 |
10.14 |
60.85 |
16% |
7.8 |
58.51 |
11.7 |
70.21 |
|
КЦРР-656/29.05.2012 |
13.06.2012 |
13.06.2012 |
Неактивен |
2405 |
| Rosuvastatin |
II-8676/ 08.03.2004 |
CRESTOR, Film coated tablet, 20, mg, Pack: 28 |
AstraZeneca Pharmaceuticals AB, Швеция |
AstraZeneca GmbH, Germany |
55.57 |
11.11 |
66.68 |
6% |
3.33 |
58.9 |
11.78 |
70.68 |
18% |
10 |
68.9 |
13.78 |
82.68 |
|
КЦ-539/19.02.2009 |
20.03.2009 |
20.03.2009 |
Неактивен |
2405 |
| Cefepime |
II-11684/06.01.2011 |
CRITIPIME, Powder for solution for injection/infusion, 1, g, Pack: 1 |
Sandoz d.d., Словения |
Sandoz GmbH |
12.13 |
2.43 |
14.56 |
6% |
0.73 |
12.86 |
2.57 |
15.43 |
18% |
2.18 |
15.04 |
3.01 |
18.05 |
|
КЦ-2453/12.07.2011; НСР-9850/21.07.2016 |
02.09.2016 |
02.09.2016 |
Заличен |
1072 |
| Cefepime |
II-11684/06.01.2011 |
CRITIPIME, Powder for solution for injection/infusion, 1, g, Pack: 1 |
Sandoz d.d., Словения |
Sandoz GmbH |
12.13 |
2.43 |
14.56 |
6% |
0.73 |
12.86 |
2.57 |
15.43 |
18% |
2.18 |
15.04 |
3.01 |
18.05 |
|
КЦ-2453/12.07.2011 |
26.07.2011 |
26.07.2011 |
Неактивен |
1072 |
| D-Penicillamine |
20040084 |
CUPRENIL, Film coated tablet, 250, mg, Pack: 100 |
Teva B.V., Нидерландия |
Teva Operations Poland Sp.z.o.o, Krakow, Poland |
186.23 |
37.25 |
223.48 |
4% |
7.45 |
193.68 |
38.74 |
232.42 |
16% |
25 |
218.68 |
43.74 |
262.42 |
Промяна на обстоятелствата НСР-16981/12.10.2018 |
HCР-6757/23.07.2015. |
08.08.2015 |
02.11.2018 |
Активен |
842 |
| D-Penicillamine |
20040084 |
CUPRENIL, Film coated tablet, 250, mg, Pack: 100 |
Teva Pharmaceuticals Polska Sp z.o.o., Полша |
Teva Operations Poland Sp.z.o.o, Krakow, Poland |
186.23 |
37.25 |
223.48 |
4% |
7.45 |
193.68 |
38.74 |
232.42 |
16% |
25 |
218.68 |
43.74 |
262.42 |
|
HCР-6757/23.07.2015. |
08.08.2015 |
08.08.2015 |
Неактивен |
842 |
| D-Penicillamine |
II-6088/30.10.2009 |
CUPRENIL, Film coated tablet, 250, mg, Pack: 100 |
Teva Pharmaceuticals Polska Sp z.o.o., Полша |
TEVA Kutno S.A., Poland |
34.99 |
7 |
41.99 |
4% |
1.4 |
36.39 |
7.28 |
43.67 |
16% |
5.6 |
41.99 |
8.4 |
50.39 |
Цената е заличена с решение НСР-6756/23.07.2015 (в сила от 16.08.2015) |
КЦ-1202/11.12.2009 |
30.12.2009 |
30.12.2009 |
Заличен |
842 |
| Natural phospholipids |
9600101 |
CUROSURF, Endotracheopulmonary instillation, suspension, 80 mg/ ml - 1,5 ml, mg, Pack: 2 |
Chiesi Farmaceutici SpA, Италия |
Chiesi Farmaceutici S.p.A., Via Palermo 26/A, 43100 Parma - Italy |
895.4 |
179.08 |
1074.48 |
4% |
10 |
905.4 |
181.08 |
1086.48 |
16% |
25 |
930.4 |
186.08 |
1116.48 |
Промяна на обстоятелства НСР-14950/01.02.2018 |
НСР-7528/19.11.2015. |
05.12.2015 |
02.03.2018 |
Активен |
454 |
| Natural phospholipids |
II-15200/12.12.2006 |
CUROSURF, Endotracheopulmonary instillation, suspension, 80 mg/ ml - 1,5 ml, mg, Pack: 2 |
Chiesi Farmaceutici SpA, Италия |
Chiesi Farmaceutici S.p.A., Via Palermo 26/A, 43100 Parma - Italy |
895.4 |
179.08 |
1074.48 |
4% |
10 |
905.4 |
181.08 |
1086.48 |
16% |
25 |
930.4 |
186.08 |
1116.48 |
|
НСР-7528/19.11.2015. |
05.12.2015 |
05.12.2015 |
Неактивен |
454 |
| Natural phospholipids |
II-15200/12.12.2006 |
CUROSURF, Endotracheopulmonary instillation, suspension, 80 mg/ ml - 1,5 ml, mg, Pack: 2 |
Chiesi Farmaceutici SpA, Италия |
Chiesi Farmaceutici S.p.A., Via Palermo 26/A, 43100 Parma - Italy |
895.4 |
179.08 |
1074.48 |
4% |
10 |
905.4 |
181.08 |
1086.48 |
16% |
25 |
930.4 |
186.08 |
1116.48 |
|
НСР-7528/19.11.2015. |
05.12.2015 |
05.12.2015 |
Неактивен |
454 |
| Natural phospholipids |
II-15200/12.12.2006 |
CUROSURF, Endotracheopulmonary instillation, suspension, 80 mg/ ml - 1,5 ml, mg, Pack: 2 |
Chiesi Farmaceutici SpA, Италия |
Chiesi Farmaceutici S.p.A., Via Palermo 26/A, 43100 Parma - Italy |
895.4 |
179.08 |
1074.48 |
4% |
10 |
905.4 |
181.08 |
1086.48 |
16% |
25 |
930.4 |
186.08 |
1116.48 |
|
НСР-7528/19.11.2015. |
05.12.2015 |
05.12.2015 |
Неактивен |
454 |
| Natural phospholipids |
II-15200/12.12.2006 |
CUROSURF, Endotracheopulmonary instillation, suspension, 80 mg/ ml - 1,5 ml, mg, Pack: 2 |
Chiesi Farmaceutici SpA, Италия |
Chiesi Farmaceutici S.p.A., Via Palermo 26/A, 43100 Parma - Italy |
923.07 |
184.61 |
1107.68 |
4% |
10 |
933.07 |
186.61 |
1119.68 |
16% |
25 |
958.07 |
191.61 |
1149.68 |
|
КЦ-450/21.01.2009 |
11.02.2009 |
11.02.2009 |
Неактивен |
454 |
| Timolol |
14892/20.11.2006 г. |
Cusimolol 0.25%, Eye drops, solution, 2.5mg/ml - 5ml, mg, Pack: 1 |
Алкон България ЕООД, България |
Alcon Cusi S.A., Испания |
2.25 |
0.45 |
2.7 |
7% |
0.16 |
2.41 |
0.48 |
2.89 |
20% |
0.45 |
2.86 |
0.57 |
3.43 |
цената се заличава с решение НСР-8009/08.02.2016. (в сила от 02.03.2016) |
НСР-3533/16.05.2014 |
31.05.2014 |
31.05.2014 |
Заличен |
2854 |
| Timolol |
14892/20.11.2006 г. |
Cusimolol 0.25%, -, 2.5mg/ml - 5ml, mg, Pack: 1 |
Алкон България ЕООД, България |
Alcon Cusi S.A., Испания |
3.01 |
0.6 |
3.61 |
7% |
0.21 |
3.22 |
0.64 |
3.86 |
20% |
0.6 |
3.82 |
0.76 |
4.58 |
|
КЦ-665/05.03.2009 |
19.03.2009 |
19.03.2009 |
Неактивен |
2854 |
| Timolol |
20000047 |
Cusimolol 0.5%, Eye drops, solution, 5mg/ml - 5ml, mg, Pack: 1 |
Novartis Pharma GmbH, Германия |
Alcon Cusi S.A., Испания |
2.35 |
0.47 |
2.82 |
7% |
0.16 |
2.51 |
0.5 |
3.01 |
20% |
0.47 |
2.98 |
0.6 |
3.58 |
промяна обстоятелства НСР-13829/12.09.2017; НСР-14590/08.12.2017 |
НСР-3289/24.04.2014 |
08.05.2014 |
02.01.2018 |
Активен |
2727 |